Endogenous endophthalmitis in a rheumatoid patient on tumor necrosis factor alpha blocker
The development of anti-tumor necrosis factor (TNF) therapies is a milestone in the therapy of rheumatic diseases.It is of concern whether all potential Carving Set undesired complications of therapy have been evaluated within clinical trials which have led to treatment approval.Specialists prescribing Oscilloscopes TNF blockers should be aware of